ArticleOncotarget2015

HDACi inhibits liposarcoma via targeting of the MDM2-p53 signaling axis and PTEN, irrespective of p53 mutational status.

Wen-Bin Ou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.